Although brucellosis is one of the world's most common zoonoses, there is a lack of data from sub-Saharan Africa [@b1],[@b2]. Brucellosis impacts on human and animal health [@b3] and has important economic consequences [@b4]. This report describes the isolation and genetic characterization of *Brucella abortus* strains from Togo, which posed a diagnostic challenge due to deletions in a gene targeted by PCR and the inability to grow on selective medium.

During a brucellosis serosurvey in Togo (2011--2012) [@b5], joint fluid was aspirated aseptically from nine seropositive cows from five herds with hygromas in the carpi/hocks. Sterile swab tips were soaked in the fluid and sealed in liquid Amies medium. After storage and transportation at 4°C according to international biosafety standards, they were cultivated in Switzerland on tryptic soy agar plates supplemented with 5% sheep blood (BD, Allschwil, Switzerland) and on *Brucella*-medium base agar supplemented with 5% inactivated horse serum and modified *Brucella* selective supplement (Oxoid, Basingstoke, UK). The plates were incubated for 10 days at 37°C in 5% CO~2~. All culture manipulations were performed under Biosafety Level 3 containment. Although there was no growth on *Brucella* selective medium, mixed cultures grew on blood agar. *Brucella*-like colonies were purified and isolates were recovered from three cows from three different herds.

Phenotypic testing of the strains was performed. The strains did not require CO~2~ for growth and grew in the presence of thionin (0.04 mg/mL and 0.02 mg/mL) and basic fuchsine (0.02 mg/mL). They produced H~2~S, as detected by hydrogen sulphide test strips (Sigma Aldrich, Buchs, Switzerland), and were urease positive (Oxoid). These results indicated *B. abortus* biovar 3 [@b6].

Molecular identification of the genus *Brucella* was performed by real-time PCR, as previously described [@b7]. As a species-specific signal for *abortus* or *melitensis* could not be obtained but *B. abortus* was suspected, it was decided to amplify a larger DNA segment of the target locus of the real-time PCR, which was specific for the species *abortus*, the BruAb2_0168 gene (BAbS19_II01580 in vaccine strain S19). The primer pair used was 0168_Babo_1F and 0168_Babo_1R. The PCR products were sequenced (primers in Table[1](#tbl1){ref-type="table"}). Two deletions of 2678 and 263 base pairs were identified, from nucleotide positions 984-3662 and 4295-4558 of the sequence of *B. abortus* strain S19 (Fig.[1](#fig01){ref-type="fig"}) (GenBank accession number: KC847095).

###### 

Primers used for the amplification and sequencing of the BruAb2_0168 gene

  Primers         Sequences (5′ to 3′)
  --------------- -------------------------
  0168_Babo_1F    GGCGTGTATGTTGTTGGTAA
  0168_Babo_2F    AACATATCGGCGACGCAGTA
  0168_Babo_3F    GTGACGGGGACGGGTTGGAC
  0168_Babo_4F    TGCGGATAATAATCTGGGTGA
  0168_Babo_5F    CGGTTAATGGCACGCTTGAA
  0168_Babo_6F    CCTCAATGGTGCGTGGGACAA
  0168_Babo_7F    CGGTTCTGGGTGGCACGGTTA
  0168_Babo_8F    GCACGGGCAGTCTGACGAAG
  0168_Babo_9F    GGCGGCACGACGACGGTTGATG
  0168_Babo_11F   GGATACTGACGGCACGCTTGA
  0168_Babo_14F   GAACTTCATATCGGTACTGGTG
  0168_Babo_15F   CTTGGTGATGACAATTCCAAGA
  0168_Babo_16F   GTCTTTTGTGCTCAAGAACAATC
  0168_Babo_17F   TGTCGTCAATGGCGGGCGATGGA
  0168_Babo_18F   GGGAGTGCAGGCAATCACAG
  0168_Babo_19F   CAGGCACGCTGACGCTGA
  0168_Babo_20F   ATACACTGACGCTTCAGAACA
  0168_Babo_1R    ATCGCCACCAACCATCAGC
  0168_Babo_2R    CGCCGTCAGACTGCCCTCCA
  0168_Babo_3R    ACCGTCGTTGCGCCCGTA
  0168_Babo_4R    AAGTGCCGCCGTTAAACGTCA
  0168_Babo_5R    GTGCCTGTGCCGCTCTTCA
  0168_Babo_6R    AATTATTCGCCGCATCCTCA
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The isolated strains displayed features that complicated diagnosis. Firstly, none grew on *Brucella* selective medium. As some *B. melitensis* and *B. abortus* strains are sensitive to the antibiotic concentrations in modified *Brucella* selective supplement, it is therefore advisable to concurrently inoculate a standard growth medium or modified Thayer-Martin plate [@b8]. Secondly, the deletions in the BruAb2_0168 gene suggest that this may not be a suitable target for an *abortus* species-specific PCR. Samples for which a species-specific signal cannot be obtained should always be tested for a genus-specific signal to ensure that *Brucella* sp is not missed. False negatives due to deletions in targets of diagnostic assays can have important public health consequences. In Sweden, a deletion of 377 base pairs in the target of a commercial PCR for the diagnosis of *Chlamydia trachomatis* was identified following a decrease in the number of human cases detected [@b9]. Genomes can undergo modifications such as deletions, insertions or rearrangements, and this aspect of bacterial evolution must always be considered when performing PCR assays for detection and/or identification. Ideally, more than one target should be tested and unexpected results investigated.

Loci with a variable number of tandem repeats (VNTR) can be used as markers to identify species belonging to the *Brucella* genus (panel 1 markers) and to discriminate among *Brucella* strains (panel 2A and 2B markers). Molecular typing by multiple locus VNTR analysis (MLVA) over 16 loci can be used as a molecular epidemiology tool to assess brucellosis transmission patterns [@b10],[@b11].

MLVA was performed on the three culture lysates and on *B. melitensis* strain 16M^T^. For most loci, sequencing confirmed the exact PCR product length. However, five loci could not be sequenced (bruce06, bruce07, bruce09, bruce30, bruce55) and their length was determined by comparing the PCR product bands with those of *B. melitensis* 16M^T^ on an agarose gel, and by the Agilent 2100 Bioanalyzer using a DNA 1000 LabChip kit (Agilent Technologies, Waldbronn, Germany) followed by comparison with the results of De Santis *et al*. [@b12]. The MLVA data were analysed using the *Brucella* aggregated database on MLVAnet (<http://mlva.u-psud.fr/>) hosted by Université Paris-Sud [@b13]. This database compares queried strains with described strains and performs a clustering analysis using the categorical coefficient and unweighted pair group method with arithmetic mean (UPGMA). The resultant Newick strings were imported into R statistical software Version 2.12.2 (<http://www.R-project.org>) and a dendogram was drawn using the package 'ape' (<http://ape-package.ird.fr/>). The three strains showed distinct VNTR profiles (Table[2](#tbl2){ref-type="table"}) clustering with African strains of *B. abortus* biovar 3 (Fig.[2](#fig02){ref-type="fig"}), confirming the phenotypic results. There is only one other genotyped strain of *B. abortus* reported from West Africa, isolated from the Gambia [@b14]. Furthermore, the three strains were obtained from a small geographical zone, the sampling sites being only 13--42 km from one another. This demonstrates the diversity of the circulating strains. Given the importance of semi-nomadic herd management and cross-border trade in Togo [@b15], livestock movements are likely to play a role in this genetic diversity.

###### 

MLVA results for three *Brucella abortus* strains from Togo over 16 loci

  Strain   Number of repeats at each locus[a](#tf2-1){ref-type="table-fn"}                                                              
  -------- ----------------------------------------------------------------- --- --- ---- --- --- --- --- ---- ---- --- --- --- --- --- ---
  JF5296   3                                                                 5   3   11   2   2   3   3   10   41   8   4   2   3   8   4
  JF5298   3                                                                 5   3   11   2   2   3   3   8    41   8   4   2   3   5   4
  JF5301   3                                                                 5   3   11   2   2   3   3   8    41   8   4   2   3   6   4

The name of each locus begins with 'bruce', followed by the corresponding number.

The three strains differ at loci bruce18 and bruce16.
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In developing countries, culture is often not feasible due to inadequate laboratory biosafety. At the time of joint fluid collection, several drops were also added to 1 mL of a chaotropic lysis buffer [@b16]. DNA extraction was performed in Switzerland as previously described [@b17]. Real-time PCR [@b7] confirmed the *Brucella* genus for six cows, three of which were culture positive. The use of inactivated, buffered samples is therefore both safer and more sensitive than culture, and is recommended for resource-poor, remote areas. Given that DNA extraction and PCR were performed 10 months after collection, rapid sample processing is not required.

More molecular data are needed from sub-Saharan Africa, in order to develop more suitable diagnostic assays for brucellosis and better understand the epidemiology of this important disease. Incoherent diagnostic results should always be further investigated.
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